home.social

#glp-1 — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #glp-1, aggregated by home.social.

fetched live
  1. GLP-1 therapeutics continue advancing beyond diabetes treatment. SureNano's novel triple agonist platform targets improved efficacy and tolerability in one of medicine's fastest-growing markets. #GLP1 #Biotech

  2. SureNano Science advances GEP-44, a next-gen GLP-1 candidate targeting obesity and metabolic disease as the market exceeds $200B. The company focuses on improved efficacy and alternative delivery options. #GLP1 #Biotech

  3. SureNano Science launches FDA-aligned IND-enabling program for GEP-44, a promising GLP-1 therapy targeting obesity and diabetes. Preclinical data rivals market leaders as the company advances toward clinical trials. #GLP1 #Biotech

  4. SureNano Science highlighted in BioMedWire editorial for next-gen GLP-1 innovation. Subsidiary GlucaPharm developing GEP-44 peptide for obesity and metabolic disease with improved tolerability. #GLP1 #Biotech

  5. SureNano Science featured in BioMedWire for next-gen GLP-1 innovation. GlucaPharm's GEP-44 peptide targets obesity and metabolic disorders with improved tolerability and non-injectable delivery options. #GLP1 #Biotech

  6. SureNano Science advances next-generation GLP-1 platform with GEP-44, a novel triple agonist peptide targeting obesity and metabolic disease. #GLP1 #Biotech

  7. The GLP-1 supply chain as Law I migration: as demand for peptides explodes, the bottleneck shifts from drug discovery to manufacturing capacity. Same pattern as AI infra — the physical constraint determines the ceiling.

    #GLP1 #Pharma #Bottleneck

  8. DATE: May 11, 2026 at 10:22AM
    SOURCE: PSYCHIATRIC TIMES

    Direct article link at end of text block below.

    A large meta-analysis found that GLP-1 drugs don’t raise depression or suicidality and modestly boost quality of life and eating control in diabetes/obesity. Read the research here: t.co/kQhtEQEPur

    Here are any URLs found in the article text:

    t.co/kQhtEQEPur

    Articles can be found by scrolling down the page at Articles can be found at psychiatrictimes.com/news".

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #GLP1 #diabetes #obesity #qualityoflife #mentalhealthBenefits

  9. CW: Weightloss

    Something that can be pretty demoralising - losing weight at the size I am - is how little difference it makes at first.

    Most people losing 2 stone, would consider it a huge milestone and it would definitely be noticeable.
    But I’m still wearing the same clothes and I’m looking the same in the mirror.
    Some clothes are a little roomier. Maybe.

    Still. Keep going.

    #TaperingTroggie #GLP1 #Weightloss #Diet #WeightlossJourney

  10. CW: Weightloss

    Check in day again.
    I got cross at my scales because for the second time since I got them a couple of weeks ago, they showed a higher weight once I was recording via the app.
    The only change was I had my phone in my hand! My phone does not weight half a kilo FFS.

    Decided I didn’t trust putting them on the mosaic floor of the bathroom any more. Took them down to the reliable lino in the kitchen and what do you know? Back down. 0.9kg lost this week.

    So I am now officially one 💩 away from 2 stone total loss. In 7 weeks. I guess that’s ok.

    #TaperingTroggie #GLP1 #Weightloss #Diet #WeightlossJourney

  11. The Impact of GLP-1 Drugs on Bariatric Surgery Rates in the U.S.

    📰 Original title: Ozempic Is Killing Off Weight Loss Surgeries. That’s a Problem

    🤖 IA: It's clickbait ⚠️
    👥 Usuarios: It's clickbait ⚠️

    View full AI summary: killbait.com/en/the-impact-of-

    #health #glp1 #bariatricsurgery...

  12. CW: Weightloss, negative self talk

    Well I did it anyway.

    It was hard to go do it, hard to do it and hard to accept that I FINALLY WALKED A MILE because if nothing else I’m a stubborn bastard.
    It doesn’t feel like it’s an achievement.
    *What? You did what you were supposed to be doing!*

    How am I ever supposed to feel good about this if I’m incapable of releasing the reward chemicals when I do the “right” thing? Fuck knows.

    #TaperingTroggie #GLP1 #Weightloss #Diet #WeightlossJourney

  13. CW: Weightloss, negative self talk

    I have to go get on the walking pad. I’ve ordered D out of the house because I can’t possibly do it with him here. So I have to do it. If I don’t then why am I even doing this?
    I could buy a reasonable amount of cake instead of a new pen of wegovy.
    Walking is doing nothing to lose the weight. Even though it hurts already. You’re not doing enough. You haven’t even managed to do a mile yet.
    But if you don’t do it today then you’re failing.
    So you might as well give up now.

    #TaperingTroggie #GLP1 #Weightloss #Diet #WeightlossJourney

  14. CW: Weightloss, negative self talk

    Another check in day. I’m 0.8kg down. Or 0.5kg if you believe the scales when I stepped on to do the official weight on the app as opposed the same scales literally 2 minutes prior.

    Feels like I’ve hit a bit of a plateau and I’m not handling it particularly well. I don’t know if it’s hormones but I’m feeling pretty nihilistic about the whole process today.

    Not helped by taking the extremely ill-advised step of calculating how long it’d take to get to X weight at my current rate of loss.
    3 years. Over 3 years actually. And I’d still be considered obese. I’d still get doctors telling me to lose weight. I’d still be seen as fat.

    But it’s fine because a couple of pounds a week is *good* weightloss right? It’s sustainable. It’s healthy.

    No. It’s not fast enough. So my brain starts doing what it does and did you know 3 years is? That’s £6,350 worth of wegovy. To still be fat? Assuming the price doesn’t go up, which it definitely will.
    But I’m almost certainly not going to have the money to keep taking it by then.
    Also I’ll be over 50 and it’s only going to get harder to lose once I fully hit menopause.

    I’m 11kg down now and I’ve noticed no difference. I could probably lose another 11kg and still not look or feel any different.

    The fact that just sorting diet out is not enough already. I have to look at increasing exercise and that terrifies me. I hate admitting that because the shame it brings. But the amount of pain and discomfort that comes with that is a monumental Great Wall like 10 million feet high that is and always has been my biggest obstacle.

    I’m tearful. I’m angry. Every cell of my brain is screaming at me to just give up.

    #TaperingTroggie #GLP1 #Weightloss #Diet #WeightlossJourney

  15. #GLP-1 is having another amazing side effect. Lowering C02! This study estimates that 851k truckloads per year, have been removed from the market due to GLP-1s, and this number could ramp to 1.95m by 2030. Less trucks, less C02

  16. #GLP1 microdosers are chasing longevity
    More than 10% of US adults take GLP-1 drugs. Around one in seven users has “microdosed” injections. Some take tiny portions for practical reasons, such as cutting costs. Others have loftier ambitions: They hope to harness the drugs’ powerful effects to achieve better health and longer lives without losing a lot of weight or experiencing side effects such as GI issues and muscle loss.
    sciencenews.org/article/glp1-m
    archive.ph/utfJ2

  17. Ozempic vs Wegovy vs Rybelsus: Comparative Analysis (2026) Semaglutide, known by the brand names Ozempic, Wegovy, Rybelsus and others, is the latest weight-loss craze to hit Hollywood and beyond. T...

    #diabetes #mellitus #GLP-1 #pharma #semaglutide #weight #loss

    Origin | Interest | Match
  18. $1.8 миллиарда, два брата и ноль проверок: как The New York Times попалась на AI-хайп

    Второго апреля я наткнулся на статью The New York Times про MEDVi — телехелс-стартап, который якобы вырос до $1.8 миллиарда с двумя сотрудниками и горой AI-инструментов. Честно? Я впечатлился. Сэм Альтман предсказывал компанию на миллиард с одним основателем — и вот она, пожалуйста. Мэттью Галлахер, 41 год, Лос-Анджелес, $20 тысяч стартового капитала, ChatGPT, Claude, Midjourney — и $401 миллион выручки за 2025 год. Я уже начал набрасывать план статьи. «Вот оно, будущее. Смотрите, как AI меняет правила игры.» А потом сделал то, что делаю всегда перед публикацией, — полез проверять факты. И статья превратилась в совершенно другую историю.

    habr.com/ru/articles/1026726/

    #AI #искусственный_интеллект #телемедицина #медиакритика #фактчекинг #стартапы #GLP1

  19. Amazon startet in den USA ein Programm für Abnehmspritzen: Arzttermine, Rezept und Lieferung in einer App. GLP-1 wird zur Plattformfrage im Gesundheitsmarkt. #Amazon #GLP1 winfuture.de/news,158239.html?

  20. "So much of the experimentation with GLP-1s is happening outside traditional research models, careful clinical trials and even the health system."

    Julia Belluz for The New York Times: nytimes.com/interactive/2026/0

    #Longreads #Medicine #Health #Ozempic #GLP1 #WeightLoss #Drugs

  21. An acylated GLP-1/GIP analogue peptide forms a uniquely porous spiral crystal structure composed of clockwise-ascending monomers in a square pattern #GLP1 #Peptides #Crystallization doi.org/10.1107/S2053230X26001

  22. The Clinician’s Definitive Guide to Peptides: Mechanisms, Evidence, Clinical Applications, and Safety (2026 Edition) Peptides are short chains of amino acids (typically 2–50 residues) that func...

    #GLP-1 #peptides

    Origin | Interest | Match
  23. Ozempic vs Wegovy vs Mounjaro vs Trulicity (2026): Evidence-Based Comparison of GLP-1 Weight Loss Drugs TL;DR  Best weight loss:  Mounjaro Best overall balance:  Wegovy Safest long-term data:  ...

    #diabetes #mellitus #GLP-1 #insulin #resistance #weight #loss

    Origin | Interest | Match
  24. Retatrutide vs Tirzepatide vs Semaglutide: Best Weight Loss Peptides in 2026 Retatrutide is an investigational triple-agonist therapy that targets three metabolic hormone pathways, potentially enab...

    #diabetes #mellitus #GLP-1 #peptides #weight #loss

    Origin | Interest | Match